BALAXI PHARMACEUTICALS LIMITED (BALAXI) — Cash Flow Quality Index
BALAXI PHARMACEUTICALS LIMITED (BALAXI) has a Cash Flow Quality Index of 29.99x as of September 2025. Operating cash flow of Rs149.66 Million exceeds net income of Rs4.99 Million, indicating high earnings quality where cash backs reported profits. Explore BALAXI cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
BALAXI PHARMACEUTICALS LIMITED Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for BALAXI PHARMACEUTICALS LIMITED across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check BALAXI PHARMACEUTICALS LIMITED cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for BALAXI PHARMACEUTICALS LIMITED (2013–2025)
Year-by-year earnings quality comparison for BALAXI PHARMACEUTICALS LIMITED. For live market cap and the full company financial profile, see BALAXI company net worth.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -1.51x | Rs-377.82 Million | Rs250.70 Million | ▼ -162.4% |
| 2024 | 2.41x | Rs48.66 Million | Rs20.15 Million | ▲ +2162.3% |
| 2023 | 0.11x | Rs60.75 Million | Rs569.22 Million | ▼ -83.0% |
| 2022 | 0.63x | Rs341.44 Million | Rs545.22 Million | ▲ +895421.0% |
| 2021 | 0.00x | Rs31.00K | Rs443.29 Million | ▲ +100.0% |
| 2020 | -1.58x | Rs-140.62 Million | Rs88.74 Million | ▼ -156.5% |
| 2019 | -0.62x | Rs-15.07 Million | Rs24.39 Million | ▼ -143.0% |
| 2015 | 1.44x | Rs2.11 Million | Rs1.47 Million | ▲ +165.7% |
| 2014 | -2.19x | Rs-2.39 Million | Rs1.10 Million | ▼ -129.8% |
| 2013 | 7.34x | Rs3.25 Million | Rs442.13K | — |